HRSA-25-052: Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas
Closed
This grant is closed. A newer notice from the same program is forecast: Ryan White HIV/AIDS Program Part C Capacity Development Program (HRSA-27-069). Status: Expected deadline March 16, 2027. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants to nonprofits and tribes. It expected to make about 6 awards worth $3.1 million in total. Applications closed on December 10, 2024.
From the official notice on Grants.gov, last changed October 8, 2024. Checked November 7, 2026.
- Total funding$3.1 million
- Expected awards6
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-22-017 | September 30, 2021 | Closed December 10, 2021 | Closed |
Key dates
| Posted | October 8, 2024 |
|---|---|
| Deadline | December 10, 2024 |
Who can apply
This opportunity was open to nonprofits and tribes.
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
This competition is open to current recipients and new, eligible applicants proposing to provide comprehensive primary health care and support services in outpatient settings for low income, uninsured, and underserved people with HIV in the service areas as described in Appendix C. You can apply if your organization provides services in the service areas described in Appendix C, is in the United States, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau, is a public or non-profit private entity, and, as identified in section 2652(a)(1) of the PHS Act, is one of the following types of eligible organizations: Federally-qualified health center under section 1905(1)(2)(B) of the Social Security Act; Grant recipient under section 1001 of the PHS Act (regarding family planning) other than States; Comprehensive hemophilia diagnostic and treatment centers; Rural health clinics; Health facilities operated by or pursuant to a contract with the Indian Health Service; Community-based organizations, clinics, hospitals, and other health facilities that provide early intervention services to people who contracted HIV through intravenous drug use; or Nonprofit private entities that provide comprehensive primary care services to populations at risk of HIV, including faith-based and community-based organizations. Native American tribal governments and organizations are eligible.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
HRSA-25-052 announces the opportunity to apply for funding under Ryan White HIV/AIDS Program (RWHAP) Part C Early Intervention Services (EIS) Program: Limited Existing Geographic Service Areas. The purpose of this program is to provide comprehensive primary health care and support services in an outpatient setting for low-income people with HIV. Under this announcement, successful applicants must provide: (1) counseling for individuals with respect to HIV; (2) targeted HIV testing; (3) periodic medical evaluations of individuals with HIV and clinical and diagnostic services for HIV care and treatment; (4) therapeutic measures for preventing and treating the deterioration of the immune system, and for preventing and treating conditions arising from HIV; and (5) referrals for people with HIV to appropriate providers of health care and support services. These services are to be provided directly or through referrals, contracts, or memoranda of understanding (MOUs). This competition is open to current RWHAP Part C EIS recipients and new organizations proposing to provide RWHAP Part C EIS funded services in the geographic service areas listed in Appendix C. Please note that the period of performance varies by service area. If you are applying for more than one service area, you must submit a separate application for each proposed service area. All allowable services must relate to HIV diagnosis, care, and support, and must adhere to established HIV clinical practice standards consistent with U.S. Department of Health and Human Services (HHS) Guidelines. Please refer to the HIV/AIDS Bureau (HAB) Policy Clarification Notice (PCN) 16-02 Ryan White HIV/AIDS Program Services for a list of RWHAP allowable core medical and support services and their descriptions. According to the RWHAP Part C statute: • At least 50 percent of the amount received under the award must be expended on EIS costs (except counseling and referrals/linkage to care); • At least 75 percent of the award (after reserving amounts for administrative costs, planning/evaluation, and clinical quality management (CQM)) must be expended on core medical services costs (Please note EIS is a subset of this 75 percent of the award) and; • Not more than 10 percent of the total RWHAP Part C award funds can be expended on administrative costs. Applicants seeking a waiver to the core medical services requirement must submit a waiver request with this application as Attachment 15.
Who has won Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease grants before
From fiscal 2021 to 2025, Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease (93.918) awarded $527 million across 527 grant awards, an average of $999,367 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Florida Department of Health | Florida | 10 | $10.3 million |
| Sun River Health, Inc. | New York | 2 | $4.2 million |
| Mobile County Board of Health | Alabama | 4 | $3.9 million |
| The Research Foundation for the State University of New York | New York | 2 | $3.7 million |
| Rutgers the State University of New Jersey | New Jersey | 4 | $3.7 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-069, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-25-052 still open?
No. It closed on December 10, 2024. A newer notice is forecast: HRSA-27-069, expected deadline March 16, 2027.
Who can apply for Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas?
Health Resources and Services Administration accepted applications from nonprofits and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Ryan White HIV/AIDS Program Part C Early Intervention Services Program: Limited Existing Geographic Service Areas?
Closed December 10, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $3.1 million in total across about 6 awards.
Who has won Grants to Provide Outpatient Early Intervention Services with Respect to HIV Disease grants before?
The largest recipients over five fiscal years were Florida Department of Health, Sun River Health, Inc., Mobile County Board of Health. The program made 527 awards worth $527 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)